ANALISIS FARMAKOEKONOMI TELEMEDICINE:  COST-BENEFIT ANALYSIS PADA DUA MODEL PELAYANAN KESEHATAN

Devi Ristian Octavia; Salma  Nur Azizah; Heri Wijaya; Irma Susanti; Sri Bintang Sahara Mahaputra KN; Zalina  Zahari

doi:10.51352/jim.v12i1.1031

Devi Ristian Octavia Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Lamongan, Lamongan, Jawa Timur, Indonesia
Salma Nur Azizah Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Lamongan, Lamongan, Jawa Timur, Indonesia
Heri Wijaya Departemen Farmasi, Sekolah Tinggi Ilmu Kesehatan Samarinda, Kalimantan Timur, Indonesia
Irma Susanti Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Lamongan, Lamongan, Jawa Timur, Indonesia
Sri Bintang Sahara Mahaputra KN Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Lamongan, Lamongan, Jawa Timur, Indonesia
Zalina Zahari Faculty of Pharmacy, Universiti Sultan Zainal Abidin, Besut, Campus, 22200, Besut, Terengganu, Malaysia

DOI: https://doi.org/10.51352/jim.v12i1.1031

Abstract

Health services require both direct medical costs and indirect non-medical costs, which can impose a financial burden on patients and society. Telemedicine is an innovative healthcare service that enables patients to receive medical care without the need for face-to-face visits to hospitals, thereby potentially reducing healthcare costs. As a form of remote healthcare service, telemedicine may improve service efficiency while minimizing the expenses incurred by patients. This study aimed to analyze the cost–benefit comparison between direct telemedicine services and outpatient healthcare services at Hospital X. This study used an observational design with a retrospective data collection approach. Data were collected using an observation sheet as the research instrument. The sample was selected using a purposive sampling technique based on predetermined inclusion criteria, resulting in a total of six patients. The benefits were measured using the human capital method and Benefit–Cost Ratio (BCR), and the obtained data were analyzed using a paired t-test. The results showed that the use of telemedicine services generated cost savings of IDR 985,000 per year, with a BCR value of 1.6. The statistical analysis showed a significance value of 0.071, indicating that there was no statistically significant difference between the two healthcare service models. In conclusion, telemedicine has the potential to provide cost efficiency for patients and society. Cost analysis is therefore important in determining the most beneficial healthcare service model for the community.